Loading...
CVS Health Corporation
CVS•NYSE
HealthcareMedical - Healthcare Plans
$63.58
$0.50(0.79%)
CVS Health Corporation (CVS) Financial Performance & Statements
Review CVS Health Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
4.20%
↑ 4.20%
Operating Income Growth
-38.03%
↓ 38.03%
Net Income Growth
-44.70%
↓ 44.70%
Operating Cash Flow Growth
-32.17%
↓ 32.17%
Operating Margin
2.54%
↑ 2.54%
Gross Margin
14.05%
↑ 14.05%
Net Profit Margin
1.39%
↑ 1.39%
ROE
6.98%
↑ 6.98%
ROIC
5.77%
↑ 5.77%
CVS Health Corporation (CVS) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for CVS Health Corporation stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $97.71B | $95.43B | $91.23B | $88.44B |
| Cost of Revenue | $84.81B | $82.87B | $77.85B | $75.88B |
| Gross Profit | $12.90B | $12.56B | $13.38B | $12.56B |
| Gross Profit Ratio | $0.13 | $0.13 | $0.15 | $0.14 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | -$10.00M | $0.00 | $0.00 | $0.00 |
| Operating Expenses | $10.52B | $11.73B | $10.34B | $10.29B |
| Total Costs & Expenses | $95.33B | $94.60B | $88.19B | $86.17B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $758.00M | $752.00M | $732.00M | $716.00M |
| Depreciation & Amortization | $1.15B | $1.16B | $1.15B | $1.14B |
| EBITDA | $4.03B | $2.02B | $4.22B | $3.43B |
| EBITDA Ratio | $0.04 | $0.02 | $0.05 | $0.04 |
| Operating Income | $2.37B | $832.00M | $3.04B | $2.27B |
| Operating Income Ratio | $0.02 | $0.009 | $0.03 | $0.03 |
| Other Income/Expenses (Net) | -$242.00M | -$727.00M | -$708.00M | -$691.00M |
| Income Before Tax | $2.13B | $105.00M | $2.34B | $1.58B |
| Income Before Tax Ratio | $0.02 | $0.001 | $0.03 | $0.02 |
| Income Tax Expense | $503.00M | $34.00M | $569.00M | $456.00M |
| Net Income | $1.64B | $87.00M | $1.77B | $1.11B |
| Net Income Ratio | $0.02 | $0.001 | $0.02 | $0.01 |
| EPS | $1.31 | $0.07 | $1.41 | $0.88 |
| Diluted EPS | $1.30 | $0.07 | $1.41 | $0.88 |
| Weighted Avg Shares Outstanding | $1.26B | $1.26B | $1.26B | $1.26B |
| Weighted Avg Shares Outstanding (Diluted) | $1.26B | $1.26B | $1.26B | $1.27B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan